Starting in 2026, shampoo manufacturers face the most significant regulatory overhaul in decades, with the FDA now requiring proof that ingredients are safe, mandatory facility registration, and strict labeling standards. The Cosmetics Modernization Regulatory Act (MoCRA) transforms how shampoos are regulated in the United States, shifting from a largely voluntary compliance system to one where brands must substantiate safety claims, report consumer injuries, and maintain detailed ingredient documentation .

What Changed in 2026 FDA Shampoo Regulations?

For decades, shampoo manufacturers operated under relatively loose FDA oversight. Unlike drugs, cosmetics didn't require pre-market approval before hitting store shelves. That's changing dramatically. Under MoCRA, all facilities manufacturing or processing shampoo for the U.S. market, including overseas factories, must now register with the FDA and renew that registration every two years . Each shampoo product must also be formally listed with the FDA using specific forms that include the responsible person's name, product category codes, complete ingredient lists by INCI (International Nomenclature of Cosmetic Ingredients) name, and label images .

The shift introduces what regulators call a "Responsible Person," typically the manufacturer, packer, or distributor listed on the label. This person bears legal responsibility for proving the product is safe, reporting any adverse events consumers experience, and ensuring all claims match the product's actual classification . If a shampoo claims to treat dandruff or prevent hair loss, for example, it's automatically classified as a drug and requires different approval pathways than a basic cleansing shampoo .

How Does the FDA Classify Your Shampoo?

Understanding classification is critical because it determines which rules apply. Most everyday shampoos, conditioners, and styling products are classified as cosmetics if their claims stay limited to cleansing, beautifying, or improving appearance. Phrases like "cleanses hair," "adds shine," or "smoothes hair strands" keep a product in the cosmetic category . Cosmetic shampoos don't need FDA pre-market approval, but they must comply with all MoCRA requirements, including ingredient safety documentation and adverse event reporting .

The line shifts when claims become therapeutic. Shampoos claiming to treat or prevent disease, or affect the structure or function of the body, are regulated as drugs. This includes anti-dandruff shampoos containing zinc pyrithione or salicylic acid, anti-hair loss products claiming to "treat hair loss" or "prevent baldness," and medicated shampoos claiming to "relieve scalp conditions" . Drug-classified shampoos face stricter labeling requirements and must follow specific FDA monographs that dictate exact wording for directions and warnings .

The FDA has been aggressive about enforcement. In the past year alone, the agency refused entry to nearly 3,000 products labeled as cosmetics that lacked required approvals or made unauthorized drug claims .

What Ingredient Safety Rules Apply Now?

Under MoCRA, brands must maintain or provide safety assessments for each ingredient in their formulation, toxicological risk assessments of the finished product, and exposure and margin of safety analysis . This represents a fundamental shift from the old system, where many ingredients were used without formal safety documentation. Brands can no longer simply assume an ingredient is safe because it's been used historically.

Several substances face heightened scrutiny or pending restrictions. Formaldehyde, a recognized carcinogen that causes respiratory irritation and skin allergies, remains a priority for FDA action, though a formal ban has not yet been issued as of January 2026 . However, independent studies and epidemiological data have linked formaldehyde in hair straightening products to increased risk of uterine cancer, ovarian cancer, breast cancer, and uterine fibroids, and states like California have already adopted stricter restrictions .

The FDA also plans to issue new rules on fragrance allergen disclosure in May 2026, requiring manufacturers to label specific fragrance allergens on cosmetic labels rather than hiding them under the vague term "fragrance" . Additionally, the agency plans to establish standardized testing methods for detecting asbestos in cosmetics containing talc, a long-standing concern for consumer safety .

Steps to Understanding Your Shampoo Label Under New Rules

• Product Identification: Look for a clear statement of what the product is, such as "shampoo" or "anti-dandruff shampoo," which tells you whether it's classified as a cosmetic or drug.
• Ingredient List: Ingredients must now be listed in descending order of concentration by INCI name, making it easier to identify what's actually in the bottle and cross-reference safety information.
• Responsible Person Information: The label must include the name and U.S. address of the Responsible Person who can receive consumer complaints and adverse event reports, providing accountability.
• Warning Statements: Any necessary warnings, such as allergen disclosures or usage restrictions, must be clearly stated in English on the label.
• Net Quantity: The product amount must be listed in U.S. customary units (ounces or pounds), not metric conversions.

Non-compliant labeling is one of the most common reasons shampoo products are detained at customs, so manufacturers must ensure all information is accurate, complete, and in English .

What Happens If a Shampoo Causes an Adverse Event?

MoCRA grants the FDA unprecedented enforcement power, including the ability to order mandatory recalls for the first time in cosmetics history. If a shampoo causes a serious adverse event, such as hospitalization, severe injury, or death, the Responsible Person must report it to the FDA within 15 business days of receiving the information . Additionally, an annual summary report of all adverse events, including minor reactions like rashes, must be submitted to the FDA .

The recall process works as follows: the FDA issues a written notice requesting the Responsible Person to conduct a voluntary recall; if the company fails to cooperate, the FDA may order an immediate halt to distribution; the Responsible Person can request a hearing; and a final decision on mandatory recall is made after the hearing . Failure to comply with an FDA order may result in injunctive relief or even criminal prosecution .

This represents a major shift from the past, when the FDA could only request voluntary recalls and had limited enforcement tools if companies refused to cooperate. Now, the agency has statutory authority to force action, making product safety accountability much stronger.

What Does This Mean for Overseas Manufacturers?

For shampoo manufacturers located outside the United States, the 2026 FDA requirements apply equally. All overseas OEM (original equipment manufacturer) and ODM (original design manufacturer) factories must register with the FDA and comply with the same ingredient safety, labeling, and adverse event reporting standards as domestic producers . This means that even if a shampoo is manufactured abroad, the U.S. Responsible Person listed on the label bears full legal responsibility for compliance.

The expanded regulatory framework aims to close gaps that existed under the old system, where cosmetics could enter the U.S. market with minimal safety documentation. By requiring facility registration, ingredient substantiation, and adverse event tracking, the FDA is shifting the burden of proof from the agency to manufacturers, making it their responsibility to demonstrate safety rather than the FDA's responsibility to prove harm.

For consumers, these changes mean greater transparency and accountability. Shampoo labels will provide more detailed ingredient information, fragrance allergens will be disclosed rather than hidden, and any safety concerns will be tracked and reported to regulators. For manufacturers, compliance requires investment in safety testing, documentation systems, and regulatory expertise, but it also creates a more level playing field where brands can't gain competitive advantage through lax safety practices.